Reply To: HPTN 083 results and standard of prevention?

  • Sylvia Kusemererwa

    Member
    August 5, 2020 at 8:04 pm

    They usually need more than one efficacy trial to licence a drug.

    However considering the different populations, CAB LA could be licensed for MSM and trans women, then the label updated to include cis women when the results become available.